OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope
Arthur S. Kim, Natasha M. Kafai, Emma S. Winkler, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4414-4429.e19
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

The low-density lipoprotein receptor promotes infection of multiple encephalitic alphaviruses
Hongming Ma, Lucas J. Adams, Saravanan Raju, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15

Chikungunya virus assembly and budding visualized in situ using cryogenic electron tomography
David Chmielewski, Michael F. Schmid, Graham Simmons, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1270-1279
Open Access | Times Cited: 40

A molecular understanding of alphavirus entry and antibody protection
Arthur S. Kim, Michael Diamond
Nature Reviews Microbiology (2022) Vol. 21, Iss. 6, pp. 396-407
Open Access | Times Cited: 38

Human Antibodies for Viral Infections
James E. Crowe
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 349-386
Closed Access | Times Cited: 37

Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review
Mengke Wang, Lidong Wang, Ping Leng, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129949-129949
Closed Access | Times Cited: 11

Ly6C+ monocytes in the skin promote systemic alphavirus dissemination
Autumn C. Holmes, Cormac J. Lucas, Morgan Brisse, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113876-113876
Open Access | Times Cited: 8

A chikungunya virus–like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans
Saravanan Raju, Lucas J. Adams, James T. Earnest, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 696
Open Access | Times Cited: 19

Hydrogen deuterium exchange and other mass spectrometry- based approaches for epitope mapping
Prashant N. Jethva, Michael L. Gross
Frontiers in Analytical Science (2023) Vol. 3
Open Access | Times Cited: 15

Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8
Ofer Zimmerman, Maxwell I. Zimmerman, Saravanan Raju, et al.
Cell (2023) Vol. 186, Iss. 22, pp. 4818-4833.e25
Open Access | Times Cited: 15

Antibody inhibition of influenza A virus assembly and release
Yuanyuan He, Zijian Guo, Sofie Subiaur, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 6

Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress
Lauren E. Williamson, Kristen M. Reeder, Kevin W. Bailey, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4430-4446.e22
Open Access | Times Cited: 36

The Viral Class II Membrane Fusion Machinery: Divergent Evolution from an Ancestral Heterodimer
Pablo Guardado‐Calvo, F.A. Rey
Viruses (2021) Vol. 13, Iss. 12, pp. 2368-2368
Open Access | Times Cited: 35

Recent advances in treatment Crimean–Congo hemorrhagic fever virus: A concise overview
Omid Gholizadeh, Mohammad Mahdi Jafari, Rezvane Zoobinparan, et al.
Microbial Pathogenesis (2022) Vol. 169, pp. 105657-105657
Closed Access | Times Cited: 24

Therapeutic efficacy of a potent anti-Venezuelan equine encephalitis virus antibody is contingent on Fc effector function
Jennifer L. Schwedler, Maxwell Stefan, Christine E. Thatcher, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Inducing broad-based immunity against viruses with pandemic potential
Alessandro Sette, Erica Ollmann Saphire
Immunity (2022) Vol. 55, Iss. 5, pp. 738-748
Open Access | Times Cited: 21

Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein
John M. Powers, Zoë L. Lyski, Whitney C. Weber, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 3, pp. e0011154-e0011154
Open Access | Times Cited: 11

Vaccine elicitation and structural basis for antibody protection against alphaviruses
Matthew S. Sutton, S. Pletnev, Victoria Callahan, et al.
Cell (2023) Vol. 186, Iss. 12, pp. 2672-2689.e25
Open Access | Times Cited: 11

Development of a next-generation chikungunya virus vaccine based on the HydroVax platform
Dawn K. Slifka, Hans-Peter Raué, Whitney C. Weber, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 7, pp. e1010695-e1010695
Open Access | Times Cited: 14

Novel approaches for the rapid development of rationally designed arbovirus vaccines
Joyce W. M. van Bree, Imke Visser, Jo M. Duyvestyn, et al.
One Health (2023) Vol. 16, pp. 100565-100565
Open Access | Times Cited: 8

Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge
Natasha M. Kafai, Lauren E. Williamson, Elad Binshtein, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 4
Open Access | Times Cited: 11

Developing a Prototype Pathogen Plan and Research Priorities for the Alphaviruses
Ann M. Powers, Lauren E. Williamson, Robert H. Carnahan, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_6, pp. S414-S426
Open Access | Times Cited: 5

Zoonotic mosquito-borne arboviruses: Spillover, spillback, and realistic mitigation strategies
Rafael K. Campos, Shannan L. Rossi, Robert B. Tesh, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 718
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top